Timothy R. Watkins, M.D., MSc.

Timothy R. Watkins, M.D., MSc.

Chief Medical Officer and Head of DevelopmentatContineum Therapeutics· In the 2025 proxy

Pay in FY2025Contineum Therapeutics stock -22.0% the same year

Timothy R. Watkins, M.D., MSc. was paid $1.8M in FY2025 (Dec). Contineum Therapeutics stock fell 22.0% that year.

Pay$100 in the stock at the end of FY24 → $78
Pay is from the Summary Compensation Table of each Contineum Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Contineum TherapeuticsPublic company · 1 yr
    • Chief Medical Officer and Head of Development2025 – Present · 1 yrStock in role -37%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?